News & Resources
Avandia Scandal Continues to Unfold
Avandia is a prescription drug marketed by GlaxoSmithKline (GSK). Released to the U.S. market in 1999, Avandia has been used by millions of Americans to treat Type II diabetes.
Long-Term Hospitals Offer Lackluster Care, Huge Profits
In traditional hospitals, patients have an attending physician or doctors on staff to treat them in the event that their condition worsens. Unfortunately, Medicare loopholes have created an industry of so-called "long-term hospitals" where extended-stay patients are transferred to from traditional hospitals.
More Woes for Medtronic and FDA as ICD Leads Continue to Fail
For patients with a high risk of cardiac-related death, implantable cardioverter-defibrillators (ICDs) are usually a demonstrably favorable alternative to medication.
Dr. Rita Redberg and her colleagues at the UCSF Medical Center have published a startling report regarding the FDA’s approval of cardiovascular drugs. According to the report, from 2000-2007 the FDA approved 78 cardiovascular devices with relatively little evidence.
The Government Accountability Office (GAO) has compiled a report looking at the steps the FDA has been taking to improve communication between the internal offices of the FDA, in an effort to protect the public from dangerous drugs released on the U.S. market.
